@article{ref1,
title="Update: Demographic, product, and substance-use characteristics of hospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injuries -United States, December 2019",
journal="MMWR: Morbidity and mortality weekly report",
year="2019",
author="Lozier, Matthew J. and Wallace, Bailey and Anderson, Kayla and Ellington, Sascha and Jones, Christopher M. and Rose, Dale A. and Baldwin, Grant and King, Brian A. and Briss, Peter and Mikosz, Christina A.",
volume="68",
number="49",
pages="1142-1148",
abstract="<p> What is already known about this topic?  Patients with e-cigarette, or vaping, product use–associated lung injury (EVALI) in Illinois and Wisconsin reported using a variety of tetrahydrocannabinol (THC)-containing products in the 3 months preceding illness; a product labeled “Dank Vapes” was most commonly reported.  What is added by this report?  Nationally, Dank Vapes were the most commonly reported THC-containing product by hospitalized EVALI patients, but a wide variety of products were reported, with regional differences. Data suggest the outbreak might have peaked in mid-September.  What are the implications for public health practice?  These data further support the association of EVALI with THC-containing products; it is unlikely that one brand is responsible for the outbreak. CDC recommends that persons not use e-cigarette, or vaping, products that contain THC ...</p> <p>Language: en</p>",
language="en",
issn="0149-2195",
doi="10.15585/mmwr.mm6849e1",
url="http://dx.doi.org/10.15585/mmwr.mm6849e1"
}